(LEN, LEN.B)

Role: Co-CEO & President, Director
Signature: /s/ Mark Sustana as Attorney-in-Fact for Jonathan M. Jaffe
Stock symbol: LEN, LEN.B
Transactions as of: Feb 28, 2024
Transactions value $: -$7,317,650
Form type: 4
Date filed: 3/1/2024, 04:19 PM
Previous filing: Jan 10, 2024
Next filing: Jan 15, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LEN, LEN.B	Class A Common Stock	Award	$0	+52.6K	+5%	$0.00	1.1M	Feb 28, 2024	Direct	F1
transaction	LEN, LEN.B	Class A Common Stock	Tax liability	-$7.32M	-47.6K	-4.31%	$153.80	1.06M	Feb 28, 2024	Direct	F2
holding	LEN, LEN.B	Class A Common Stock						1.58K	Feb 28, 2024	By ESOP Trust
holding	LEN, LEN.B	Class B Common Stock						23.2K	Feb 28, 2024	Direct
holding	LEN, LEN.B	Class B Common Stock						198	Feb 28, 2024	By ESOP Trust

Showing 1 to 5 of 5 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 26, 2021, the reporting person was granted a target award of 68,312 shares of Class A common stock subject to performance-based vesting conditions over a three-year performance period ended November 30, 2023. This grant was reported when it occurred. As a result of meeting specified performance criteria, on February 14, 2024, the 68,312 shares of Class A common stock vested and the reporting person was granted an additional 52,600 shares of Class A common stock.
F2	Pursuant to a 10b5-1 plan, the reporting person surrendered shares to pay tax liability on the shares of Class A common stock that were subject to performance criteria. The grant of shares subject to performance-based vesting conditions was originally made on February 26, 2021.

Content

On February 26, 2021, the reporting person was granted a target award of 68,312 shares of Class A common stock subject to performance-based vesting conditions over a three-year performance period ended November 30, 2023. This grant was reported when it occurred. As a result of meeting specified performance criteria, on February 14, 2024, the 68,312 shares of Class A common stock vested and the reporting person was granted an additional 52,600 shares of Class A common stock.

Pursuant to a 10b5-1 plan, the reporting person surrendered shares to pay tax liability on the shares of Class A common stock that were subject to performance criteria. The grant of shares subject to performance-based vesting conditions was originally made on February 26, 2021.